Genotoxic Impurities in Pharmaceutical Industry Hybrid Conference

26th-27th of January 2023, 9:00 CET

Barcelona 

Event page

Register now

Download Agenda

ABOUT CONFERENCE

We are pleased to welcome you to the Genotoxic Impurities in Pharmaceutical Industry Hybrid Conference that will take place in Barcelona, Spain on the January 26-27, 2023 and online on the BigMarker Platform (Hybrid version).

The conference is containing case studies from large and small pharmaceutical companies in multiple geographical regions. It is a unique opportunity to get the latest technical insights and discuss Rapidly Advancing Technologies and Latest Trends & Innovations in Toxicology & Pharmaceutical sectors.

Genotoxic Impurities in Pharmaceutical Industry Hybrid Conference is a great platform for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic questions & answers sessions as well as panel discussions and workshops with keynote speakers.

MEDIA PARTNER

Key points

  • Recent advances in Impurity profiling
  • Pharmaceutical Issues
  • Genotoxic impurity identification and control
  • Toxicity and Drug Testing
  • Analytical Technologies for Genotoxic Impurities

Who should attend

CxOs, VPs, Directors, Heads, Managers, Principal Scientists of

  • Genotoxic Impurities/ GTIs/ Genotoxins/ Elemental Impurities
  • Genotoxicity/ Mutagenicity
  • Carcinogenicity/ Carcinogens
  • Genetic Toxicology/ Chemical Toxicology/ Computational Toxicology
  • Analytical Chemistry/ Analytical Development/ Analytical Science
  • Drug Discovery/ Drug Development/ Drug Substance
  • Drug Safety/ Compound Safety
  • Process Chemistry/ Process Development
  • Product Characterisation/ Risk Assessment
  • Pharmacokinetics/ Metabolism
  • Extractables & Leachables
  • API Development/ Degradation Products
  • LC-MS/ Mass Spectrometry
  • Good Laboratory Practice (GLP)/ Good Manufacturing Practice (GMP)
  • Regulatory Affairs & Compliance

2-DAYS HYBRID CONFERENCE INCLUDES

  • 11+ different topics
  • panel discussion
  • networking with business professionals and industry experts
  • additional materials
If you would like to participate, kindly book your spot. The seats are limited.
Broadcast Link will be provided via email post registration.

8:30 – 9:00 CET

REGISTRATION & WELCOME DRINK

9:00 – 9:10 CET

OPENING REMARKS FROM BCF REPRESENTATIVE

9:10 – 9:30 CET

NETWORKING

9:30 – 9:40 CET

WELCOME & OPENING REMARKS FROM THE CHAIRMAN, OPENING REMARKS FOR ONLINE DELEGATES

9:40 – 10:20 CET

Genotoxicity Evaluation of a Complex N-nitroso-impurity + Q&A

10:20 – 11:00 CET

Testing of Genetoxic Impurities in Drug Products – Pig-a Assay: A Novel in vivo Gene Mutation Assay + Q&A

11:00 – 11:40 CET

Predicting DNA-Reactivity of N-Nitrosamines: A Quantum Chemical Approach + Q&A

11:40 – 11:55 CET

COFFEE BREAK

11:55 – 12:40 CET

Nitrosamines in Pharmaceuticals +Q&A

12:40 – 13:20 CET

European Pharmacopoeia Activities on the Control of Genotoxic Impurities with Special Focus on Nitrosamines + Q&A

13:20 – 14:00 CET

Boronic Acids as Genotoxic Impurities in the Pharmaceutical Industry + Q&A

14:00 – 15:00 CET

NETWORKING LUNCH

15:00 – 15:20 CET

SPONSOR SLOT

15:20 – 16:00 CET

Risk Assessment of Genotixic Impurities: Justification Of Safe Limits + Q&A

16:00 – 16:40 CET

Nitrosamine Impurities – Possible options for Risk Assessment Using Genetic Toxicity Data + Q&A

16:40 – 17:00 CET

COFFEE BREAK & NETWORKING

17:00 – 17:20 CET

PANEL DISCUSSION: What Are Key Challenges Facing Drug Manufacturers Today Regarding Genotoxic Impurities?

17:20 – 17:30 CET

CLOSING REMARKS

19:00 – 21:00 CET

COCKTAIL RECEPTION & NETWORKING TIME

09:00 – 09:30 CET

REGISTRATION & WELCOME DRINK

09:30 – 09:40 CET

OPENING REMARKS FROM BCF REPRESENTATIVE

09:40 – 09:50 CET

WELCOME & OPENING REMARKS FROM THE CHAIRMAN, OPENING REMARKS FOR ONLINE DELEGATES

09:50 – 10:30 CET

Setting Limits for Complex Nitrosamines + Q&A

10:30 – 11:10 CET

TBA + Q&A

11:10 – 11:25 CET

COFFEE BREAK

11:25 – 12:05 CET

TBA + Q&A

12:05 – 12:45 CET

TBA + Q&A

12:45 – 13:45 CET

LUNCH TIME

13:45 – 13:55 CET

CLOSING REMARKS AND EVALUATION TIME

SPEAKERS

OUR PARTNERS

Contact Us

Maria Babenkova
Conference Producer
Tel.: +420 228 227 163
E-mail: maria.babenkova@bcf-events.com
Valerie Neumann
Senior Marketing Manager
Tel.: +420 228 227 162
E-mail: valerie.neumann@bcfgroup.eu
Daria Novoseltseva
Business Development Manager
Tel.: +420 228 227 163
E-mail: daria.novoseltseva@bcf-events.com